谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Brief Report of Durvalumab with or Without Tremelimumab in Combination with Chemotherapy As First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

Edward B. Garon,Byoung Chul Cho,Alexander Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Dmytro Trukhin, Sang -We Kim,Grygorii Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Milena Kohlmann, Caitlin Lowery,Helen Mann,Solange Peters,Tony S. Mok,Melissa L. Johnson

CLINICAL LUNG CANCER（2024）

引用 1|浏览47
关键词
Immunotherapy,Immune checkpoint inhibitor,Programmed cell death ligand-1,Cytotoxic T-lymphocyte-associated antigen 4,Clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要